Abstract:

Abstract: The incidence rate of cervical cancer in pregnancy is about 1/10000.According to tumor types，clinical stage，gestational weeks and the wishes of patients to continue pregnancy，it is recommended to take cisplatin-basedmonotherapy or combined neoadjuvant chemotherapy regimens until the fetus reaches maturity.Neoadjuvant chemotherapy （NACT） is an innovative approach in the management of these patients，and it does not significantly increase the risk of birth defects，but long-term concern should be given to the impact onthe mother and baby's health.

Key words: cervical cancer；neoadjuvant chemotherapy, pregnancy

摘要：

妊娠合并宫颈癌发病率约为1/10000，应根据肿瘤类型、期别、妊娠孕周情况及患者本人强烈保留胎儿意愿，进行以铂为基础单药或联合方案的新辅助化疗，延长妊娠时间至胎儿成熟。新辅助化疗不明显增加新生儿畸形发生率，但需长期关注化疗对母儿的影响。

关键词: 宫颈肿瘤, 新辅助化疗, 妊娠